methoxyhydroxyphenylglycol has been researched along with buprenorphine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kleber, HD; Kosten, TR; Morgan, C | 1 |
| Cowan, A; Dettmar, PW; Walter, DS | 1 |
| Cruz-Santa, Y; De Jesús-Burgos, MI; González-García, S; Pérez-Acevedo, NL | 1 |
1 trial(s) available for methoxyhydroxyphenylglycol and buprenorphine
| Article | Year |
|---|---|
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1992 |
2 other study(ies) available for methoxyhydroxyphenylglycol and buprenorphine
| Article | Year |
|---|---|
A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats.
Topics: Animals; Biogenic Amines; Brain Chemistry; Buprenorphine; Dopamine; Haloperidol; Homovanillic Acid; Male; Methoxyhydroxyphenylglycol; Morphinans; Morphine; Norepinephrine; Rats; Serotonin | 1981 |
Amygdalar activation of group I metabotropic glutamate receptors produces anti- and pro-conflict effects depending upon animal sex in a sexually dimorphic conditioned conflict-based anxiety model.
Topics: Amygdala; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Buprenorphine; Conditioning, Psychological; Conflict, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Estradiol; Female; Gene Expression Regulation; Male; Methoxyhydroxyphenylglycol; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Sex Characteristics | 2016 |